Fabian CJ - Search Results

1

Biomarker and cytologic abnormalities in women at high and low risk for breast cancer.

Fabian CJ, Zalles C, Kamel S, McKittrick R, Moore WP, Zeiger S, Simon C, Kimler B, Cramer A, Garcia F, et al. Fabian CJ, et al. J Cell Biochem Suppl. 1993;17G:153-60. doi: 10.1002/jcb.240531129. J Cell Biochem Suppl. 1993. PMID: 7911861

2

Use of biomarkers for breast cancer risk assessment and prevention.

Fabian CJ, Kimler BF. Fabian CJ, et al. J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):31-9. doi: 10.1016/j.jsbmb.2007.05.022. Epub 2007 May 24. J Steroid Biochem Mol Biol. 2007. PMID: 17596932

3

Prevalence of aneuploidy, overexpressed ER, and overexpressed EGFR in random breast aspirates of women at high and low risk for breast cancer.

Fabian CJ, Zalles C, Kamel S, Kimler BF, McKittrick R, Tranin AS, Zeiger S, Moore WP, Hassanein RS, Simon C, et al. Fabian CJ, et al. Breast Cancer Res Treat. 1994;30(3):263-74. doi: 10.1007/BF00665967. Breast Cancer Res Treat. 1994. PMID: 7981444

4

Identification of a chemoprevention cohort from a population of women at high risk for breast cancer.

Fabian CJ, Kamel S, Zalles C, Kimler BF. Fabian CJ, et al. J Cell Biochem Suppl. 1996;25:112-22. J Cell Biochem Suppl. 1996. PMID: 9027607 Clinical Trial.

5

Breast cytology and biomarkers obtained by random fine needle aspiration: use in risk assessment and early chemoprevention trials.

Fabian CJ, Zalles C, Kamel S, Zeiger S, Simon C, Kimler BF. Fabian CJ, et al. J Cell Biochem Suppl. 1997;28-29:101-10. J Cell Biochem Suppl. 1997. PMID: 9589354

6

Breast cancer chemoprevention trials using the fine-needle aspiration model.

Kimler BF, Fabian CJ, Wallace DD. Kimler BF, et al. Among authors: fabian cj. J Cell Biochem Suppl. 2000;34:7-12. J Cell Biochem Suppl. 2000. PMID: 10762008

7

Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model.

Fabian CJ, Kimler BF, Zalles CM, Klemp JR, Kamel S, Zeiger S, Mayo MS. Fabian CJ, et al. J Natl Cancer Inst. 2000 Aug 2;92(15):1217-27. doi: 10.1093/jnci/92.15.1217. J Natl Cancer Inst. 2000. PMID: 10922407

8

Chemoprevention for high-risk women: tamoxifen and beyond.

Fabian CJ, Kimler BF. Fabian CJ, et al. Breast J. 2001 Sep-Oct;7(5):311-20. doi: 10.1046/j.1524-4741.2001.21570.x. Breast J. 2001. PMID: 11906441 Review.

9

Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside.

Fabian CJ, Kimler BF, Zalles CM, Klemp JR, Petroff BK, Khan QJ, Sharma P, Setchell KD, Zhao X, Phillips TA, Metheny T, Hughes JR, Yeh HW, Johnson KA. Fabian CJ, et al. Cancer Prev Res (Phila). 2010 Oct;3(10):1342-50. doi: 10.1158/1940-6207.CAPR-10-0022. Epub 2010 Aug 19. Cancer Prev Res (Phila). 2010. PMID: 20724470 Free PMC article. Clinical Trial.

10

Favorable modulation of benign breast tissue and serum risk biomarkers is associated with > 10 % weight loss in postmenopausal women.

Fabian CJ, Kimler BF, Donnelly JE, Sullivan DK, Klemp JR, Petroff BK, Phillips TA, Metheny T, Aversman S, Yeh HW, Zalles CM, Mills GB, Hursting SD. Fabian CJ, et al. Breast Cancer Res Treat. 2013 Nov;142(1):119-32. doi: 10.1007/s10549-013-2730-8. Epub 2013 Oct 19. Breast Cancer Res Treat. 2013. PMID: 24141897 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters